Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited Fundamental Analysis
Apollo Hospitals Enterprise Limited (APOLLOHOSP.NS) shows moderate financial fundamentals with a PE ratio of 58.38, profit margin of 7.44%, and ROE of 21.28%. The company generates $242.2B in annual revenue with strong year-over-year growth of 14.35%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze APOLLOHOSP.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakAPOLLOHOSP.NS struggles to generate sufficient returns from assets.
Valuation Score
WeakAPOLLOHOSP.NS trades at a premium to fair value.
Growth Score
ExcellentAPOLLOHOSP.NS delivers strong and consistent growth momentum.
Financial Health Score
ExcellentAPOLLOHOSP.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateAPOLLOHOSP.NS maintains healthy but balanced margins.
Key Financial Metrics
Is APOLLOHOSP.NS Expensive or Cheap?
P/E Ratio
APOLLOHOSP.NS trades at 58.38 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, APOLLOHOSP.NS's PEG of 7.50 indicates potential overvaluation.
Price to Book
The market values Apollo Hospitals Enterprise Limited at 11.57 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 28.32 times EBITDA. This signals the market has high growth expectations.
How Well Does APOLLOHOSP.NS Make Money?
Net Profit Margin
For every $100 in sales, Apollo Hospitals Enterprise Limited keeps $7.44 as profit after all expenses.
Operating Margin
Core operations generate 18.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.28 in profit for every $100 of shareholder equity.
ROA
Apollo Hospitals Enterprise Limited generates $8.21 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Apollo Hospitals Enterprise Limited generates limited operating cash flow of $13.26B, signaling weaker underlying cash strength.
Free Cash Flow
Apollo Hospitals Enterprise Limited generates weak or negative free cash flow of $6.19B, restricting financial flexibility.
FCF Per Share
Each share generates $43.04 in free cash annually.
FCF Yield
APOLLOHOSP.NS converts 0.59% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
58.38
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
7.50
vs 25 benchmark
P/B Ratio
Price to book value ratio
11.57
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.34
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.88
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.64
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.21
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.26
vs 25 benchmark
How APOLLOHOSP.NS Stacks Against Its Sector Peers
| Metric | APOLLOHOSP.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 58.38 | 28.54 | Worse (Expensive) |
| ROE | 21.28% | 738.00% | Weak |
| Net Margin | 7.44% | -43982.00% (disorted) | Weak |
| Debt/Equity | 0.88 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.64 | 2806.01 | Neutral |
| ROA | 8.21% | -14624.00% (disorted) | Weak |
APOLLOHOSP.NS outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Apollo Hospitals Enterprise Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
87.50%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
207.55%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
44.36%
Industry Style: Defensive, Growth, Innovation
High Growth